Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Merck KGaA, Yamanouchi to codevelop two new cardiovascular drug candidates

May 13, 1998

MK-886 demonstrates antihyperplastic activity in an animal model of intimal thickening

May 13, 1998

Azimilide: a unique new antiarrhythmic agent in phase III development

May 12, 1998

Roche and Nortran join forces for development of atrial arrhythmia drugs

May 11, 1998

Proteus seeks partners, licensees for novel hypertension vaccine

May 8, 1998

Roche now copromoting Coreg with SKB

May 8, 1998

E-4010: a potential new treatment for pulmonary hypertension

May 8, 1998

Scios submits NDA for Natrecor

May 6, 1998

Bisaramil compared to lidocaine for effects on Na+ channels

May 6, 1998

C-C chemokines implicated in the pathogenesis of CHF

May 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...